ArticleJournal of thoracic disease2026
Experience with H anastomosis and its perioperative management protocol in minimally invasive esophagectomy: a propensity score-matched comparison with stapled non-enhanced recovery after surgery pathway.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: H anastomosis is an emerging esophagogastric reconstruction technique that has shown promising perioperative results. However, real-world comparative evidence, particularly from rigorously matched cohorts, remains limited. Therefore, the present study aimed to compare short-term postoperative recovery metrics between the H anastomosis pathway and a stapled anastomosis pathway using propensity score matching (PSM). Methods: This single-center retrospective study compared patients who underwent H anastomosis pathway between October 2024 and July 2025 (n=100) with those who received stapled anastomosis pathway between October 2023 and July 2024 (n=102). PSM was applied in a 1:1 ratio (75 matched pairs) based on age, sex, body mass index (BMI), and neoadjuvant therapy (NAT). Postoperative hospital stay (PHS) and postoperative fasting duration (PFD), modeled as overdispersed count variables, were analyzed using negative binomial regression. For low-frequency events-including severe pulmonary infection (SPI), reinsertion, and anastomotic leakage (AL)-Firth's penalized logistic regression was used to reduce small-sample bias. Binary postoperative outcomes-including hypoalbuminemia, fever, high-grade fever, tachycardia, and atrial fibrillation (AF)-were evaluated using standard logistic regression. Results: The H anastomosis pathway group demonstrated significantly shorter PHS and PFD (PHS: 10.27±4.19 Conclusions: Although superiority cannot yet be claimed, our findings indicate that H anastomosis, when implemented together with its coordinated perioperative management protocol, provides a stable and feasible enhanced recovery after surgery (ERAS) oriented pathway for minimally invasive esophagectomy (MIE).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.